Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098319
Filing Date
2024-11-14
Accepted
2024-11-14 15:30:33
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220081-10q_optimizerx.htm   iXBRL 10-Q 850289
2 CERTIFICATION ea022008101ex31-1_optimizerx.htm EX-31.1 9261
3 CERTIFICATION ea022008101ex31-2_optimizerx.htm EX-31.2 9214
4 CERTIFICATION ea022008101ex32-1_optimizerx.htm EX-32.1 5225
  Complete submission text file 0001213900-24-098319.txt   4249945

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE oprx-20240930.xsd EX-101.SCH 31352
6 XBRL CALCULATION FILE oprx-20240930_cal.xml EX-101.CAL 41227
7 XBRL DEFINITION FILE oprx-20240930_def.xml EX-101.DEF 165506
8 XBRL LABEL FILE oprx-20240930_lab.xml EX-101.LAB 303217
9 XBRL PRESENTATION FILE oprx-20240930_pre.xml EX-101.PRE 175768
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0220081-10q_optimizerx_htm.xml XML 454314
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38543 | Film No.: 241461020
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)